|
BCL7A expression based on
|
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.58592999999208E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.61985999999059E-05 |
| Normal-vs-Stage2 |
3.133600E-02 |
| Normal-vs-Stage3 |
2.542600E-03 |
| Normal-vs-Stage4 |
9.400700E-03 |
| Stage1-vs-Stage2 |
5.232600E-01 |
| Stage1-vs-Stage3 |
5.031800E-01 |
| Stage1-vs-Stage4 |
6.675000E-01 |
| Stage2-vs-Stage3 |
8.947600E-01 |
| Stage2-vs-Stage4 |
8.543200E-01 |
| Stage3-vs-Stage4 |
9.394600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.1162000000039E-05 |
| Normal-vs-AfricanAmerican |
4.221600E-03 |
| Normal-vs-Asian |
2.973500E-04 |
| Caucasian-vs-AfricanAmerican |
1.678200E-01 |
| Caucasian-vs-Asian |
2.673400E-01 |
| AfricanAmerican-vs-Asian |
6.332200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.678020E-03 |
| Normal-vs-Female |
4.66539999999238E-06 |
| Male-vs-Female |
4.003600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.13769999999336E-05 |
| Normal-vs-Age(41-60Yrs) |
1.586080E-04 |
| Normal-vs-Age(61-80Yrs) |
2.737500E-03 |
| Normal-vs-Age(81-100Yrs) |
6.865200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.854600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.665000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.592400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.425600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.206840E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.396960E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.061600E-02 |
| Classical-VS-Follicular |
3.396100E-03 |
| Classical-VS-Other |
9.949200E-01 |
| Classical-VS-Normal |
1.32549999976028E-07 |
| Tall-VS-Follicular |
7.155600E-01 |
| Tall-VS-Other |
3.360800E-01 |
| Tall-VS-Normal |
6.510400E-02 |
| Follicular-VS-Other |
3.680200E-01 |
| Follicular-VS-Normal |
1.380790E-01 |
| Other-VS-Normal |
1.869640E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.240100E-04 |
| Normal-vs-N1 |
1.387910E-02 |
| N0-vs-N1 |
7.489400E-01 |
|
|
